Singapore · Delayed Price · Currency is SGD HGH Holdings Statistics
Total Valuation
HGH Holdings has a market cap or net worth of SGD 30.27 million. The enterprise value is 40.04 million.
| Market Cap | 30.27M |
| Enterprise Value | 40.04M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HGH Holdings has 1.78 billion shares outstanding. The number of shares has increased by 1.15% in one year.
| Current Share Class | 1.78B |
| Shares Outstanding | 1.78B |
| Shares Change (YoY) | +1.15% |
| Shares Change (QoQ) | +7.65% |
| Owned by Insiders (%) | 59.66% |
| Owned by Institutions (%) | 14.39% |
| Float | 718.39M |
Valuation Ratios
The trailing PE ratio is 5.86.
| PE Ratio | 5.86 |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.59, with an EV/FCF ratio of -13.09.
| EV / Earnings | 7.66 |
| EV / Sales | 0.73 |
| EV / EBITDA | 3.59 |
| EV / EBIT | 6.65 |
| EV / FCF | -13.09 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.39 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.47 |
| Debt / FCF | -5.37 |
| Interest Coverage | 16.05 |
Financial Efficiency
Return on equity (ROE) is 10.72% and return on invested capital (ROIC) is 8.42%.
| Return on Equity (ROE) | 10.72% |
| Return on Assets (ROA) | 4.70% |
| Return on Invested Capital (ROIC) | 8.42% |
| Return on Capital Employed (ROCE) | 9.09% |
| Weighted Average Cost of Capital (WACC) | 3.88% |
| Revenue Per Employee | 252,981 |
| Profits Per Employee | 24,185 |
| Employee Count | 216 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 142.19 |
Taxes
In the past 12 months, HGH Holdings has paid 889,000 in taxes.
| Income Tax | 889,000 |
| Effective Tax Rate | 14.60% |
Stock Price Statistics
The stock price has increased by +6.25% in the last 52 weeks. The beta is 0.12, so HGH Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +6.25% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 34.63 |
| Average Volume (20 Days) | 19,295,300 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HGH Holdings had revenue of SGD 54.64 million and earned 5.22 million in profits. Earnings per share was 0.00.
| Revenue | 54.64M |
| Gross Profit | 13.96M |
| Operating Income | 6.02M |
| Pretax Income | 6.09M |
| Net Income | 5.22M |
| EBITDA | 10.75M |
| EBIT | 6.02M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 6.52 million in cash and 16.41 million in debt, with a net cash position of -9.89 million or -0.01 per share.
| Cash & Cash Equivalents | 6.52M |
| Total Debt | 16.41M |
| Net Cash | -9.89M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 51.12M |
| Book Value Per Share | 0.03 |
| Working Capital | 9.53M |
Cash Flow
In the last 12 months, operating cash flow was -632,000 and capital expenditures -2.43 million, giving a free cash flow of -3.06 million.
| Operating Cash Flow | -632,000 |
| Capital Expenditures | -2.43M |
| Depreciation & Amortization | 4.73M |
| Net Borrowing | 4.96M |
| Free Cash Flow | -3.06M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 25.54%, with operating and profit margins of 11.01% and 9.56%.
| Gross Margin | 25.54% |
| Operating Margin | 11.01% |
| Pretax Margin | 11.14% |
| Profit Margin | 9.56% |
| EBITDA Margin | 19.68% |
| EBIT Margin | 11.01% |
| FCF Margin | n/a |
Dividends & Yields
HGH Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.15% |
| Shareholder Yield | -1.15% |
| Earnings Yield | 17.26% |
| FCF Yield | -10.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 25, 2016. It was a forward split with a ratio of 5.359056806.
| Last Split Date | Nov 25, 2016 |
| Split Type | Forward |
| Split Ratio | 5.359056806 |
Scores
HGH Holdings has an Altman Z-Score of 1.81 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 3 |